Social network
Investors - Ensuring sustainable growth
Investors - Ensuring sustainable growth

Investors

Ensuring sustainable growth

Tools content (print, share, increase/decrease text size):

 

Individual shareholders

Dear individual shareholder,
Welcome to this section especially dedicated to you. Throughout these pages we provide our individual shareholders and all those who are interested in our shares with information on the Company’s commitment towards its shareholders.
If you want to learn more about Sanofi, contact the Sanofi Individual Shareholder Relations team in:
France at +33 800 075 876 or
the United States at +1 888 516 3002.

 

First quarter results 2017

First quarter results 2017 will be reviewed by management during a conference call with the financial community on April 28, 2017 at 2:30 pm CEST / 8:30 am EDT.

 

Letter to shareholders - March 2017

This new issue focuses on fourth-quarter and full year 2016 results, the launch of SoliquaTM, the KevzaraTM approval in Canada, the Sanofi Consumer Healthcare global business unit (GBU) and the digitalization of the Letter to shareholders.

 

Electronic subscription to our publications

In 2017, the Letter to Shareholders becomes more digital.
We invite you to share our commitment to minimize the environmental impact of our publications by privileging the electronic subscription to the Letter to Shareholders and the Shareholder Handbook.

 

SHAREHOLDER MEETING in Lille

On March 15, 2017, Sanofi participated in a shareholder meeting in Lille.

 

Consensus

Sanofi makes available to shareholders the estimates of the Analysts Consensus published by Vara Research GmbH.

 

Right area:

Stock Market

IR mobile application

SANOFI IR - The Investor Relations Mobile Application

SANOFI IR is available on iPhone, iPad, Apple Watch and Android!
NEW - Section dedicated to Individual Shareholders

 

Annual General Meeting 2017

The Sanofi General Meeting will be held on May 10, 2017 at the Palais de Congrès in Paris, France.

 

Shareholder Handbook

Sanofi at a glance

 

© Sanofi 2004-2017 - All rights reserved - Update: April 13, 2017

  • Site complies with W3C WCAG 2.0 (new window, in english)